Joel L. Wherley - 05 Aug 2026 Form 4 Insider Report for CHEMED CORP (CHE)

Reporting relationship: CEO - Vitas Healthcare
Issuer ticker: CHE
Reported as of: 05 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Aug 2026, 14:17:09 UTC
Prior SEC filing: 17 Feb 2026
Source filing: View source filing
Reporting owner signature: Joel L. Wherley

Key filing fact

Joel L. Wherley filed Form 4 for CHEMED CORP (CHE) on 06 Aug 2026.

Key facts

This page summarizes Joel L. Wherley's Form 4 filing for CHEMED CORP (CHE).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Aug 2026, 14:17.

Change

Previous filing in this sequence was filed on 17 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002083070 Primary reporting owner

Wherley Joel L

Relationship: CEO - Vitas Healthcare
Address: 255 EAST FIFTH STREET, SUITE 2600, CINCINNATI
Signature: Joel L. Wherley
Signature date: 06 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CHE transaction

Capital Stock

Options Exercise

Transaction value
Shares: +2,599
Change %: +305%
Price: $445.35^*
Shares after: 3,451
Date: 05 Aug 2026
Ownership: Direct

CHE transaction

Capital Stock

Tax liability

Transaction value
Shares: -2,270
Change %: -66%
Price: $542.62^*
Shares after: 1,181
Date: 05 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CHE transaction Derivative

Stock Option (right to buy with tandem tax withholding)

Options Exercise

Transaction value
Shares: -2,599
Change %: -7.9%
Price: $445.35^*
Shares after: 30,220
Date: 05 Aug 2026
Ownership: Direct
Underlying class: Capital Stock
Underlying amount: 2,599
Exercise price: $445.35
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Payment of purchase price and tax obligation on stock option exercise.

Footnote F2

Vesting in three equal annual installments commencing 10/28/2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .